Page 7 - Agvhd News Today

Perhaps surprisingly when considering interest rates are rising – usually a negative for high-yield assets – high-dividend stocks and the related exchange traded funds are delivering for investors this year.

Low-volatility stocks are outperforming the broader market this year. Same goes for high-dividend equities.

Broadly speaking, dividend stocks and the related exchange traded funds are among the most durable shelter-from-the-storm plays.

FRIDAY, Aug. 26, 2022 (HealthDay News) -- The U.S. Food and Drug Administration has approved Imbruvica (ibrutinib) for pediatric patients with chronic graft versus host disease (cGVHD) after failure of

Franklin Templeton president and CEO Jenny Johnson spoke with NYSE's Judy Shaw for "ETF Leaders, Powered by the New York Stock Exchange."

Some exchange traded funds are versatile across a variety of market settings, but some of these funds can and do truly shine under specific circumstances.

The Naugatuck Valley Health District Gives Back Program is highlighting the The Diaper...

With the S&P 500 coming off its worst first-half showing in 50 years, it’s fair to say that not much is working with equities this year.

The first half of 2022 was brutal for equity investors, with the S&P 500 dropping 20.6% and marking the worst start to the year since 1970.

Broadly speaking, dividend ETFs are outperforming the broader market this year, but investors still need to evaluate what’s driving that outperformance.